TeraWulf exhibits critical financial instability, highlighted by a Piotroski F-Score of 1/9, indicating severe deterioration in fundamental health. The company's valuation is completely detached from its operational reality, with a Price/Sales ratio of 59.24 and a Forward P/E of 5092.50 despite an operating margin of -210.53%. While analysts maintain a 'strong_buy' rating and historical price action has been explosive, the combination of catastrophic EPS growth (-800% YoY) and significant insider selling by the CEO and CFO suggests a speculative bubble.